This could occur through mechanisms, such as promoting the aggregation of immune cells around tumours, reducing the activity of antigen-presenting cells, shifting immune responses from Th1 to Th2 and Th17 or inhibiting the functions of CD8+ cytotoxic T cells and NK cells, all of which contribute to facilitating tumour immune escape. This evidence concerns the gene CD8A and neoplasm.